Time in range was similar among pediatric patients with type 1 diabetes who used either the Insulet Omnipod 5 or the Tandem Control IQ.

Discover key insights from West Pharmaceutical Services' Q4 2024 earnings call, highlighting growth in GLP-1 elastomers, biologics, and HVP components.

Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an ...

Today, Benzinga's options scanner identified 8 options transactions for DexCom. This is an unusual occurrence. The sentiment ...

Adults with insulin-treated type 2 diabetes had a significant HbA1c decline at 13 weeks with use of the Omnipod 5 automated ...

Wall Street edged back from its all-time high on Friday, as U.S. stock indexes drifted following mixed profit reports from big companies. The S&P 500 barely budged and slipped by less than 0.1%, a day ...

Wall Street is flirting with a record Friday, as U.S. stock indexes drift following mixed profit reports from big companies. The S&P 500 was edging higher by 2 points, or less than 0.1%, in late ...

Q4 2024 Earnings Call Transcript February 13, 2025 DexCom, Inc. misses on earnings expectations. Reported EPS is $0.45 EPS, expectations were $0.4792. Operator: Thank you for standing by. My name is ...

Real-time CGM can also be used for people with complex ... In clinical trials, use of the Freestyle Libre CGM range has been shown to improve blood glucose control, reducing hypoglycaemic and ...

An innovative study, co-designed by Aboriginal Women, has led to remission of type 2 diabetes. The research described and ...

Prime Minister Narendra Modi arrived at Palam airport in Delhi on Friday after concluding his two-nation visit to France and ...